Two Sigma Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Sell |
39,714
-427,600
| -92% | -$23.5M | ﹤0.01% | 1082 |
|
|
2025
Q1 | $33M | Buy |
467,314
+360,300
| +337% | +$25.5M | 0.07% | 241 |
|
|
2024
Q4 | $7.03M | Sell |
107,014
-74,300
| -41% | -$4.88M | 0.02% | 590 |
|
|
2024
Q3 | $12.7M | Sell |
181,314
-50,600
| -22% | -$3.56M | 0.03% | 423 |
|
|
2024
Q2 | $19.1M | Sell |
231,914
-313,100
| -57% | -$25.8M | 0.04% | 351 |
|
|
2024
Q1 | $47.6M | Buy |
545,014
+209,800
| +63% | +$18.3M | 0.11% | 190 |
|
|
2023
Q4 | $32.3M | Sell |
335,214
-238,300
| -42% | -$23M | 0.08% | 247 |
|
|
2023
Q3 | $50.7M | Sell |
573,514
-176,600
| -24% | -$15.6M | 0.13% | 159 |
|
|
2023
Q2 | $65M | Sell |
750,114
-259,500
| -26% | -$22.5M | 0.17% | 141 |
|
|
2023
Q1 | $98.2M | Buy |
1,009,614
+272,700
| +37% | +$26.5M | 0.25% | 93 |
|
|
2022
Q4 | $76.3M | Buy |
736,914
+340,800
| +86% | +$35.3M | 0.21% | 105 |
|
|
2022
Q3 | $33.6M | Buy |
396,114
+139,200
| +54% | +$11.8M | 0.1% | 211 |
|
|
2022
Q2 | $21.3M | Buy |
256,914
+27,800
| +12% | +$2.3M | 0.06% | 311 |
|
|
2022
Q1 | $17.7M | Buy |
229,114
+118,100
| +106% | +$9.11M | 0.05% | 353 |
|
|
2021
Q4 | $9.81M | Buy |
111,014
+51,600
| +87% | +$4.56M | 0.02% | 506 |
|
|
2021
Q3 | $4.59M | Sell |
59,414
-147,800
| -71% | -$11.4M | 0.01% | 825 |
|
|
2021
Q2 | $17.3M | Buy |
+207,214
| New | +$17.3M | 0.05% | 373 |
|
|
2020
Q2 | – | Sell |
-82,104
| Closed | -$6.94M | – | 2490 |
|
|
2020
Q1 | $6.94M | Sell |
82,104
-456,300
| -85% | -$38.6M | 0.03% | 606 |
|
|
2019
Q4 | $45.5M | Buy |
538,404
+4,800
| +0.9% | +$406K | 0.11% | 218 |
|
|
2019
Q3 | $36M | Buy |
533,604
+229,500
| +75% | +$15.5M | 0.09% | 263 |
|
|
2019
Q2 | $26M | Buy |
304,104
+189,400
| +165% | +$16.2M | 0.06% | 335 |
|
|
2019
Q1 | $10.2M | Buy |
114,704
+42,700
| +59% | +$3.79M | 0.03% | 594 |
|
|
2018
Q4 | $6.13M | Sell |
72,004
-20,900
| -22% | -$1.78M | 0.02% | 735 |
|
|
2018
Q3 | $9.01M | Buy |
92,904
+19,200
| +26% | +$1.86M | 0.02% | 622 |
|
|
2018
Q2 | $6.94M | Buy |
+73,704
| New | +$6.94M | 0.02% | 713 |
|
|
2017
Q3 | – | Sell |
-17,804
| Closed | -$1.62M | – | 2208 |
|
|
2017
Q2 | $1.62M | Sell |
17,804
-74,400
| -81% | -$6.76M | 0.01% | 1311 |
|
|
2017
Q1 | $8.09M | Buy |
92,204
+8,600
| +10% | +$755K | 0.03% | 639 |
|
|
2016
Q4 | $6.93M | Buy |
83,604
+33,331
| +66% | +$2.76M | 0.03% | 597 |
|
|
2016
Q3 | $4.65M | Buy |
+50,273
| New | +$4.65M | 0.02% | 671 |
|
|
2016
Q2 | – | Sell |
-8,804
| Closed | -$726K | – | 2049 |
|
|
2016
Q1 | $726K | Sell |
8,804
-17,372
| -66% | -$1.43M | ﹤0.01% | 1286 |
|
|
2015
Q4 | $2.74M | Sell |
26,176
-95,573
| -79% | -$10M | 0.02% | 650 |
|
|
2015
Q3 | $13.2M | Buy |
121,749
+120,269
| +8,126% | +$13.1M | 0.08% | 280 |
|
|
2015
Q2 | $202K | Buy |
+1,480
| New | +$202K | ﹤0.01% | 1748 |
|
|
2013
Q3 | – | Sell |
-14,404
| Closed | -$803K | – | 1593 |
|
|
2013
Q2 | $803K | Buy |
+14,404
| New | +$803K | 0.01% | 760 |
|